Cargando…
When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?
Recommendations have been issued for vaccinating with the Sanofi Pasteur tetravalent dengue vaccine (CYD-TDV, Dengvaxia(®)) individuals aged from 9 to 45/60 years old with a prior dengue virus (DENV) infection and living in endemic countries/areas. One question linked to these recommendations is to...
Autores principales: | Guy, Bruno, Ooi, Eng Eong, Ramos-Castañeda, Jose, Thomas, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349415/ https://www.ncbi.nlm.nih.gov/pubmed/32283639 http://dx.doi.org/10.3390/vaccines8020174 |
Ejemplares similares
-
Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
por: Bifani, Amanda Makha, et al.
Publicado: (2021) -
The re-emergence of dengue in China
por: Ooi, Eng Eong
Publicado: (2015) -
Host Cell Transcriptome Profile during Wild-Type and Attenuated Dengue Virus Infection
por: Sessions, October M., et al.
Publicado: (2013) -
Minding the “T”s beyond the “B”s: Shaping vaccines for future pandemics
por: Kalimuddin, Shirin, et al.
Publicado: (2023) -
Evolution of Subgenomic RNA Shapes Dengue Virus Adaptation and Epidemiological Fitness
por: Finol, Esteban, et al.
Publicado: (2019)